Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011849 (diabetes)
277,896 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

beta-Hexosaminidase and its isoenzyme patterns were investigated in plasma from patients with Type 1 diabetes mellitus. The patients were divided into three main groups matched for duration of diabetes: (a) proliferative retinopathy (b), progress of retinopathy within a two-year period (c) and with no background retinopathy. When all patients were compared to a reference group, a significant increase of plasma beta-hexosaminidase activity was found. Patients with proliferative retinopathy had significantly increased activity of plasma beta-hexosaminidase compared to the reference group but not compared to the other diabetic patients. The isoenzyme distribution was not different in any of the diabetic subgroups compared to the reference group. It was also shown that various degrees of diabetic nephropathy did not influence total plasma Hex or the isoenzyme pattern.
...
PMID:The association between plasma beta-hexosaminidase and its isoenzyme patterns and retinopathy in type 1 diabetes mellitus. 182 17

The scanning laser technique in combination with digital image analysis allows direct objective measurement of flow velocities in perimacular capillaries. In addition, the complete macular network of capillaries can be observed. By means of digital frame-to-frame picture analysis of digital recordings, blood flow velocities and morphologic data have been measured. The mean flow velocity in perimacular capillaries observed with the scanning laser ophthalmoscope in healthy subjects (n = 21) amounted to 3.28 +/- 0.45 mm/second. In patients (n = 13) with diabetes mellitus (no or background retinopathy), the mean flow velocity was significantly reduced (2.89 +/- 0.57 mm/seconds) compared with healthy subjects. Morphologic data of the perifoveal capillary bed showed a significant reduction of capillaries in patients with diabetes mellitus when compared with healthy subjects.
...
PMID:Retinal capillary blood flow measurement with a scanning laser ophthalmoscope. Preliminary results. 186 55

The goal of this article was to examine the differences in the rates of microvascular complications of non-insulin-dependent diabetes mellitus (NIDDM) in Hispanic and non-Hispanic white subjects. This was a geographically based case-control study where prevalent cases of NIDDM were identified in medical records. Subjects attended a 4-h clinic to confirm NIDDM diagnosis and assess complication end points. Retinopathy was defined by stereofundus photographs. Distal symmetric neuropathy was determined by standardized clinical examination. Nephropathy was indicated by serum creatinine level, urine protein-creatinine ratio, and urine albumin concentration. This study consisted of 279 NIDDM subjects confirmed by oral glucose tolerance test and World Health Organization criteria aged 20-74 yr (187 Hispanic and 92 non-Hispanic white subjects). Duration-adjusted prevalence of retinopathy was significantly higher in non-Hispanic white subjects (54.1 per 100, 95% confidence interval [CI] 44.4-63.7) than in Hispanics (41.8 per 100, 95% CI 34.8-48.8). This excess occurred only in non-Hispanic white subjects with background retinopathy but not in those with more severe retinopathy. Hispanics and non-Hispanic white subjects did not differ significantly for the prevalence of neuropathy (31.6 per 100 in non-Hispanic white subjects and 26.3 per 100 in Hispanics) or nephropathy by any measure. There were no significant differences in duration of diabetes or mean glycohemoglobin levels between ethnic groups. Microvascular complications of NIDDM are not in excess among Colorado Hispanics, and retinopathy may be somewhat more common in non-Hispanic white people.
Diabetes Care 1991 Jul
PMID:Microvascular complications of NIDDM in Hispanics and non-Hispanic whites. San Luis Valley Diabetes Study. 191 15

Our objective was to evaluate the diagnostic potential of a new vision testing procedure for detecting subclinical visual dysfunction in patients with insulin-dependent diabetes mellitus (IDDM) and minimal or absent retinopathy. We used a method which challenged both the ocular focusing and color discrimination systems simultaneously. A computerized laser speckle optometer which measured changes in ocular refraction on a subjective criterion of speckle movement rather than perceived blur was used to measure the accuracy of steady-state accommodative responses. Five volunteers between 15 and 23 years of age who had IDDM and minimal background retinopathy participated in this study. Our results for this small group of diabetics showed that: (1) the overall binocular accommodative response profiles of diabetics for colored targets through increasing negative power ophthalmic lenses did not differ markedly from those of a control population; (2) diabetics exhibited a high sensitivity for perception of optical defocus; (3) the blood glucose level influenced the extent and accuracy of accommodative responses; and (4) the overall accommodative precision, when compared to a group of nondiabetics in the same age range, showed evidence of being more reliant on target colors. The theoretical and clinical implications of these findings are discussed.
...
PMID:Accommodative performance for chromatic targets in diabetes mellitus: a preliminary report. 192 46

The effect of lipid lowering on hard exudates was determined in six consecutive patients with insulin-dependent diabetes mellitus. Diet and hypolipidemic drug therapy including the use of pravastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase, were used to treat patients for one year. The total cholesterol concentration decreased from a mean baseline value of 231 mg/dl to a treatment mean value of 165 mg/dl. The mean low-density lipoprotein cholesterol concentration decreased from 157 mg/dl to 93 mg/dl. Masked grading of fundus photographs indicated an improvement in hard exudates in all six patients and a decrease in microaneurysms in four patients. Visual acuity improved in one patient and did not change (one line or less change) in five patients. No remarkable side effects resulting from treatment were observed. Our pilot study suggests that aggressive therapy of diabetic patients with hyperlipidemia may have a beneficial effect on background retinopathy.
...
PMID:The effects of lipid lowering on diabetic retinopathy. 192 39

Macular retinal capillary hemodynamics was evaluated in 39 nonhypertensive insulin-dependent diabetic patients and 24 age-matched control subjects using the blue field entopic simulation technique. A statistically significant 25% increase in macular capillary flow velocity was observed among the diabetic eyes along with a 37% decrease in the density of the entoptically perceived leukocytes. When the eyes of diabetic patients were graded according to the modified composite scale of Klein et al, capillary flow velocity was elevated in the group without retinopathy as well as in those with mild background retinopathy and those with preproliferative or proliferative retinopathy. The density of the entopically perceived leukocytes was more severely reduced in those with retinopathy than in those without retinopathy but was poorly correlated with the composite grading scale. These results are consistent with the concept that in diabetes, capillary obstruction, either transient or permanent, may focally occur within the retina associated with vasodilation in the adjacent microvasculature because of relative tissue hypoxia.
...
PMID:Macular retinal capillary hemodynamics in diabetic patients. 196 48

The roles of potential risk factors for background and proliferative retinopathy were evaluated in cross-sectional analyses from the Epidemiology of Diabetes Complications Study, Pittsburgh, Pennsylvania. This report presents results from the 657 insulin-dependent diabetic participants seen at the baseline examination (1986-1988). The presence of and severity of retinopathy were judged from stereoscopic photographs of three views of the ocular fundus using the modified Airlie House classification system. Fifty-three percent of the participants had background retinopathy, and 31% had proliferative retinopathy. Logistic regression analyses showed that among participants aged less than 18 years, those with background retinopathy were older and had higher levels of glycosylated hemoglobin compared with those without retinopathy. In the 18-29-year age group, participants with background retinopathy had a longer duration of diabetes, higher low density lipoprotein (LDL) cholesterol levels, and lower high density lipoprotein cholesterol levels and were more likely to have microalbuminuria compared with those without retinopathy. Participants aged 18-29 years with proliferative retinopathy had a longer duration of diabetes, higher diastolic blood pressure, and higher fibrinogen and LDL cholesterol levels than those with background retinopathy. In the age group greater than or equal to 30 years, diabetes duration, diastolic blood pressure, and fibrinogen, LDL cholesterol, and triglyceride levels were increased in participants with proliferative retinopathy versus those with background retinopathy. In a multivariate model of proliferative retinopathy, controlling for concurrent renal disease weakened the influence of blood pressure, fibrinogen, triglycerides, and LDL cholesterol and improved the overall fit of the model. These results suggest that diabetic nephropathy may contribute to the development of proliferative (but not background) retinopathy by increasing blood pressure and fibrinogen, by altering the lipoprotein profile, and possibly through other mechanisms.
...
PMID:The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. 199 2

The ocular hemodynamics in diabetic patients with increasingly severe retinopathy have been evaluated using a non-invasive computerized methodology. In a group of 19 healthy volunteers the mean ophthalmic arterial pressure and the ocular pulsatile blood flow were 83 +/- 2.4 mmHg and 648 +/- 42 microliters min-1 respectively. Nine diabetics with no apparent retinopathy had ophthalmic pressures and pulsatile blood flows similar to those in the control subjects. In 11 diabetic patients with background retinopathy the mean pulsatile blood flow was 471 +/- 70 microliters min-1. Thirteen diabetics with proliferative retinopathy had a pulsatile blood flow of 210 +/- 37 microliters min-1 and abnormally low ophthalmic arterial pressures. The results provide evidence that the choroidal blood flow decreases with the severity of the retinopathy in diabetes due to increased vascular resistance and a decreased ocular perfusion pressure.
...
PMID:Choroidal blood flow in diabetic retinopathy. 201 99

The aim of study was the comparison of the Biostator-determined insulin requirement with the degree of diabetic retinopathy and previous insulin therapy. Twenty-three patients with insulin-dependent diabetes mellitus of more than 10 years' duration were studied. The mean insulin dosage during the last ten years was calculated, and the degree of retinopathy and insulin requirement during a 2-day connection to the Biostator were determined. In comparing the mean insulin supply during the last ten years with the Biostator-determined insulin requirement in patients with proliferative retinopathy, the significant difference occurred only in patients with diabetes of less than 15 years' duration (P less than 0.05). Such a difference was not found in patients with background retinopathy. We conclude that the patients with more advanced changes in the eye fundus, particularly those with diabetes of shorter duration, had received generally less insulin than was required as determined by the Biostator. It may be inferred that long-term inadequate insulin supply accelerates the development of microvascular complications in diabetes.
Diabetes Res Clin Pract 1991 Mar
PMID:Diabetic retinopathy and previous insulin therapy as compared with insulin requirement. 203 37

Metabolism of polyamines (spermidine and spermine) is known to be strictly related to the growth processes of eukaryotic cells. Since cell replication processes appear altered in insulin-dependent diabetes mellitus (IDDM), especially when associated with its microvascular complications, the aim of this study was measuring serum spermidine oxidase activity (SOA), a key enzyme in the metabolic pathway of polyamines, in 47 patients with IDDM as compared with 63 healthy control subjects matched for age and sex. Mean SOA levels +/- SD were significantly lower in IDDM patients (177.4 +/- 57.2 mu kat/l) than in controls (247.6 +/- 68.1 mu kat/l; p less than 0.001), being SOA inversely related with daily insulin dose. SOA was moreover significantly higher (but similar to controls) in the group with increased urinary albumin excretion rate (AER persistently greater than 20 micrograms/min); (n = 17; 213.1 +/- 62.6 mu kat/l) in comparison with normoalbuminuric subjects (n = 30; 156.6 +/- 43.5 mu kat/l; F = 21.78; p = 0.0001). SOA was correlated with AER (r = 0.45; p = 0.001), independently of age, duration of disease, serum creatinine, body weight, blood pressure and metabolic control, as shown by a multiple regression analysis model (p = 0.003). Presence of background retinopathy was not associated with modified levels of SOA, which was conversely higher, although not significantly, in the patients with proliferative retinal lesions. In conclusion serum SOA is deeply altered in IDDM patients, being markedly reduced in the whole group of patients and conversely independently increased up to the mean values of controls in presence of increased AER or advanced retinopathy.
...
PMID:Serum spermidine oxidase activity in patients with insulin-dependent diabetes mellitus and microvascular complications. 208 31


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>